Aortic Stenosis News and Research

RSS
UTHealth researchers examine effectiveness of Sapien 3 TAVR in low-risk patients with aortic stenosis

UTHealth researchers examine effectiveness of Sapien 3 TAVR in low-risk patients with aortic stenosis

Unidentified valvular heart disease very common in elderly

Unidentified valvular heart disease very common in elderly

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Persistent low flow warns of mortality risk after TAVR

Persistent low flow warns of mortality risk after TAVR

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Mayo researchers develop extremely precise assay to measure age-associated changes in GDF11

Mayo researchers develop extremely precise assay to measure age-associated changes in GDF11

TAVI matches SAVR for early and midterm mortality

TAVI matches SAVR for early and midterm mortality

Health of 1 million over 65s at risk from low awareness of heart valve disease

Health of 1 million over 65s at risk from low awareness of heart valve disease

Study estimates half of transcatheter heart valves undergo degeneration within 10 years

Study estimates half of transcatheter heart valves undergo degeneration within 10 years

RDAVR system improves survival of patients with severe aortic stenosis

RDAVR system improves survival of patients with severe aortic stenosis

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

TAVR procedure could provide improved health outcomes for inoperable patients

TAVR procedure could provide improved health outcomes for inoperable patients

LivaNova announces first implant of Perceval sutureless valve in PERSIST-AVR trial

LivaNova announces first implant of Perceval sutureless valve in PERSIST-AVR trial

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

Frequent TAVR to replace damaged aortic heart valve improves patient outcomes

Frequent TAVR to replace damaged aortic heart valve improves patient outcomes

Edwards Lifesciences' SAPIEN 3 transcatheter heart valve approved in Japan

Edwards Lifesciences' SAPIEN 3 transcatheter heart valve approved in Japan

Edwards Lifesciences' net sales grow 1.3% to $615.5 million in third quarter 2015

Edwards Lifesciences' net sales grow 1.3% to $615.5 million in third quarter 2015

Sorin Group initiates PERSIST-AVR trial to evaluate Perceval sutureless aortic valve against standard sutured bioprostheses

Sorin Group initiates PERSIST-AVR trial to evaluate Perceval sutureless aortic valve against standard sutured bioprostheses

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Anti-coagulant medications quickly resolve blood clots that could impair valve motion

Training session can improve cardiologists’ ability to detect basic and advanced murmurs

Training session can improve cardiologists’ ability to detect basic and advanced murmurs